50% of trials fail due to lack of enrollment. In other words, because patients don't find out about a trial and enroll, we never get to find out if the treatment could work.
The 5-year survival rate for people with cancerous brain or CNS tumors is 34% for men and 36% for women.
36% of patients NEVER discussed clinical trials with their provider
Weekly Updates Include:
1) any new trials that fit your criteria;
2) any changes in the enrollment status of a relevant trial;
(#1 & #2 as sourced via clinicaltrials.gov)
The report is printable so it can be shared with a patient and a patient’s doctors.
The gear above will be available as part of our awareness fundraising campaign.
Despite there being NO FDA approved cure
only 2-3% of cancer patients ever enroll in clinical trials.
Untreated, about 50 percent of people with RRMS transition to secondary-progressive MS (SPMS) within a decade of the initial diagnosis.
When my father was diagnosed with brain cancer, i called my dear friend Bernson for advice. He had been diagnosed with a rare Sarcoma a year earlier. He apologized for not getting back to me sooner and offered lots of positivity. When I received the call that he had passed a few days later, it occurred to me: he had selflessly spent one of his last days offering nothing but hope.
I am dedicating my work for FastTrek to Bernson, my father, and the countless courageous people who fight cancer and have fought cancer while living life to the fullest every day they can.
How do you #iFightCancer? Let us know!
Please note: This is not medical advice.
“FastTrek.org Foundation, Inc.,” its website, apps, employees, and directors are not providing medical advise via this site, its TrialTracker, or any emails or reports it provides.
Any information obtained here should be shared with a medical practitioner and/or medical specialist.